Skip to main content
Serum Institute Conducts Phase 3 Clinical Trial Of BCG Vaccine - NDTV 28-Jul-2020
Serum Institute Conducts Phase 3 Clinical Trial Of BCG Vaccine - NDTV
The Serum Institute of India is conducting phase III clinical trial of BCG vaccine candidate VPM1002 to evaluate its ability in reducing infection and severe disease outcomes of COVID-19 among high-risk persons of advanced age, comorbidities and high-exposure…
More...